Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it will host ...
Dr. Ozsvath discusses leadership in venous societies, community engagement in vascular care, venous research priorities, and ...
An Abu Dhabi resident has made a full recovery after suffering a rare type of stroke that initially presented as a severe ...
Please provide your email address to receive an email when new articles are posted on . Many variables make accurate prediction of hemodialysis start and AVF maturation nearly impossible. Several ...
12-month postapproval outcomes confirmed the safety and efficacy of Medtronic’s In.Pact AV DCB in the treatment of AV fistula stenoses in patients with ESRD on dialysis. Target lesion primary patency ...
The In.Pact AV DCB [Image courtesy of Medtronic] Medtronic (NYSE:MDT) today announced new real-world data from a post-approval study of its In.Pact AV drug-coated balloon (DCB). The IN.PACT AV Access ...
Cavernous sinus dural arteriovenous fistula (CS-DAVF) with cortical venous drainage to the spinal perimedullary veins (Cognard type V) is a rare clinical entity. The treatment becomes particularly ...
Advanced Fissure and Fistula Treatments for Minimizing Complications and Enhancing Quality of Life Bengaluru (Karnataka) [India], April 09: Anorectal conditions such as fissures and fistulas are often ...
Early postoperative ambulation plays a crucial role in accelerating postoperative recovery in pediatric patients. This study aimed to analyze the current status and associated factors of early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results